Tuberculin Syringe

Tuberculin Syringe Market Outlook

The global tuberculin syringe market has been valued at approximately USD 1.5 billion in 2023 and is projected to reach around USD 2.3 billion by 2035, growing at a CAGR of about 5.6% during the forecast period. The increasing prevalence of tuberculosis and heightened awareness surrounding vaccination practices globally are significant growth factors driving this market. Additionally, the rising focus on preventive healthcare measures and the necessity for accurate tuberculosis diagnosis and management further propel the market's expansion. As governments and healthcare organizations intensify efforts to combat TB, the demand for tuberculin syringes, which are essential in administering the Mantoux tuberculin skin test, is expected to witness a steady rise. Innovations in syringe technology, such as safety and retractable designs, are also enhancing market growth by improving safety and minimizing the risk of needle-stick injuries.

Growth Factor of the Market

Several factors contribute to the growth of the tuberculin syringe market. Firstly, the global rise in tuberculosis cases, particularly in developing regions, has resulted in increased demand for effective diagnostic tools such as tuberculin syringes. Additionally, ongoing government initiatives aimed at eradicating tuberculosis and enhancing public health infrastructure are vital in expanding access to these essential diagnostic devices. Furthermore, the technological advancements in syringe manufacturing, including the introduction of low dead space and safety syringes, have significantly improved user experience and patient safety. Moreover, the growing trend of home-based healthcare services and the increasing incidence of chronic diseases requiring regular monitoring bolster the market's demand. Lastly, the rising inclination towards preventive healthcare practices is encouraging healthcare professionals to adopt tuberculin testing, thus driving market growth.

Key Highlights of the Market

• The tuberculin syringe market is anticipated to grow at a CAGR of 5.6% from 2023 to 2035.
• Innovative syringe designs are enhancing safety and usability, leading to increased adoption.
• The rising prevalence of tuberculosis, especially in Asia and Africa, is significantly impacting market demand.
• Homecare settings are becoming a prominent segment for tuberculin syringe utilization.
• North America remains a leading market, driven by advanced healthcare facilities and infrastructure.

By Product Type

Fixed Needle Tuberculin Syringe:

The fixed needle tuberculin syringe is a traditional type that features a fixed needle attached to a barrel. This design simplifies the administration of the tuberculin skin test by ensuring that the needle does not detach during use, which can help maintain sterility and ease of handling. The fixed needle option is commonly preferred in medical settings, particularly for quick and efficient testing. With its straightforward construction, it is often cost-effective, making it an attractive choice for healthcare providers, especially in resource-limited environments. As the need for standardized testing methods grows, the fixed needle tuberculin syringe continues to hold a significant share in the market.

Detachable Needle Tuberculin Syringe:

The detachable needle tuberculin syringe provides added flexibility and convenience by allowing the user to attach or detach the needle as needed. This feature is particularly beneficial in clinical settings where multiple tests may be conducted, as it facilitates quicker transitions between syringe use without the need for entirely new syringes. The ability to replace needles also enhances safety and reduces the risk of contamination. The growing emphasis on user comfort and safety, combined with the demand for multi-purpose syringes, is propelling the popularity of detachable needle tuberculin syringes in various healthcare environments.

Safety Tuberculin Syringe:

Safety tuberculin syringes are gaining traction in the market due to their design, which minimizes the risk of needle-stick injuries. These syringes typically feature a retracting mechanism that safely withdraws the needle into the barrel after administration. As healthcare professionals prioritize safety in handling syringes, this product type is becoming increasingly essential in hospitals and clinics. The rising awareness regarding occupational health and safety guidelines is also pushing healthcare facilities to adopt safety syringes, thus contributing to market growth. Furthermore, regulatory bodies are advocating for safer injection practices, which further enhances the demand for safety tuberculin syringes.

Retractable Tuberculin Syringe:

Retractable tuberculin syringes are designed to automatically retract the needle after use, effectively reducing the risk of accidental needle-stick injuries. This advanced design ensures that the needle is safely concealed and cannot be reused, which is a critical factor in preventing infections. The increasing focus on improving safety measures in healthcare settings is driving the adoption of retractable syringes. As such syringes enhance the overall safety profile of injection practices, they are likely to witness a steady growth trajectory within the market. Healthcare organizations are increasingly investing in such innovative solutions to safeguard their staff and patients alike.

Low Dead Space Tuberculin Syringe:

Low dead space tuberculin syringes are engineered to minimize residual medication left in the syringe after administration. This feature is particularly important when precise dosages are required, as it enhances the effectiveness of the tuberculin skin test by ensuring that the full volume of the injected solution is delivered. As patient safety and accurate dosing are paramount in healthcare, the demand for low dead space syringes has been steadily increasing. The growing need for reliable and effective diagnostic tools, coupled with the trend towards more precise medical technologies, positions low dead space tuberculin syringes as a key segment in the market.

By Application

Hospitals:

Hospitals represent a significant application segment for tuberculin syringes. As major healthcare providers, hospitals conduct numerous tuberculin skin tests as part of their routine patient evaluation protocols, particularly for patients with respiratory symptoms or at risk for tuberculosis. The availability of specialized units and trained personnel allows hospitals to efficiently administer these tests, contributing to early diagnosis and treatment. In light of increased tuberculosis awareness and screening initiatives, hospitals are likely to continue investing in tuberculin syringes, further solidifying their importance in this healthcare segment.

Clinics:

Clinics, including outpatient facilities and private practices, also play a vital role in the tuberculin syringe market. They often serve as primary care sites where initial screenings occur, and the injection of tuberculin is a common procedure. The accessibility of clinics for routine check-ups encourages individuals to seek testing, thereby boosting the usage of tuberculin syringes. Moreover, with the ongoing emphasis on preventive healthcare and community health outreach, clinics are increasingly incorporating tuberculin testing into their services, thereby expanding their market share.

Diagnostic Centers:

Diagnostic centers specialize in various medical tests and screenings, including the tuberculin skin test. The convenience and efficiency of diagnostic centers in administering tests attract patients seeking quick evaluations for tuberculosis exposure or infection. These centers often utilize advanced technologies and skilled personnel to ensure accurate results, enhancing their role in public health efforts. As awareness of tuberculosis and its testing continues to rise, diagnostic centers are likely to increase their demand for tuberculin syringes, contributing to overall market growth.

Homecare Settings:

The homecare segment is emerging as a significant application area for tuberculin syringes, driven by the increasing shift towards at-home healthcare services. Patients requiring regular monitoring or those who prefer to receive care in their homes can benefit from tuberculin skin tests performed by healthcare professionals visiting them. This convenience not only enhances patient comfort but also promotes timely diagnosis and treatment of tuberculosis. As more healthcare systems adapt to provide home-centric services, the demand for tuberculin syringes in this segment is expected to expand rapidly.

Others:

Other application areas for tuberculin syringes may include research institutions, educational facilities, and public health campaigns. These venues often utilize tuberculin skin testing as part of research studies or screening initiatives aimed at understanding and controlling tuberculosis spread. The adaptability of tuberculin syringes for various uses beyond traditional healthcare settings illustrates their versatility and importance in combating TB. As public health initiatives and research efforts grow, the 'Others' segment is expected to contribute positively to the tuberculin syringe market.

By Distribution Channel

Hospitals Pharmacies:

Hospital pharmacies are significant distribution channels for tuberculin syringes as they cater to the immediate needs of healthcare facilities. These pharmacies ensure a continuous supply of essential medical equipment and supplies, including tuberculin syringes, to support ongoing patient care. Additionally, the presence of trained pharmacists within hospital settings enhances the ability to provide guidance on proper usage and safety precautions associated with these syringes. Consequently, the demand for tuberculin syringes through hospital pharmacies remains robust, driven by the need for reliable and readily available medical supplies.

Retail Pharmacies:

Retail pharmacies serve as a crucial distribution channel for consumers seeking tuberculin syringes for home healthcare or personal use. The convenience of accessing these syringes in local pharmacies appeals to individuals requiring testing or vaccinations. As more patients seek to take an active role in their healthcare, retail pharmacies are positioned to meet this demand by offering tuberculin syringes alongside proper consultation services. The growth of retail pharmacies as a distribution channel is further supported by the increasing trend of preventive healthcare and self-testing initiatives.

Online Pharmacies:

Online pharmacies are becoming increasingly popular for purchasing medical supplies, including tuberculin syringes. The convenience of online shopping, coupled with the ability to easily compare prices and access a wide variety of products, drives consumers towards this distribution channel. As telemedicine and remote healthcare services gain prominence, the demand for online pharmacies is expected to grow, particularly for products that require careful handling and delivery. The ability to provide discreet and direct access to tuberculin syringes makes online pharmacies a vital channel in the overall market landscape.

Drug Stores:

Drug stores, often synonymous with retail pharmacies, provide convenient access to tuberculin syringes for individuals seeking testing and vaccination services. These establishments are strategically located to serve local communities, and many offer additional healthcare services, such as immunizations and health screenings. As public awareness of tuberculosis testing increases, drug stores are likely to enhance their offerings of tuberculin syringes, further solidifying their role as essential distribution points within the market. The competitive pricing and accessibility of drug stores contribute to their significance in the tuberculin syringe market.

Others:

Other distribution channels may include specialized medical supply companies and direct sales to healthcare providers. These channels often target specific markets, such as research institutions, educational facilities, and government health departments, which require consistent supply chains for tuberculin syringes. The diversity of distribution channels serves to enhance the overall accessibility and availability of tuberculin syringes, ensuring that healthcare providers and consumers can obtain these critical tools as needed. The varied landscape of distribution channels is instrumental in supporting the growth of the tuberculin syringe market.

By Material Type

Plastic Tuberculin Syringe:

Plastic tuberculin syringes are widely used due to their lightweight and cost-effective nature. These syringes are typically made from high-quality, medical-grade plastics that ensure safety and sterility during use. Their disposable nature enhances convenience by reducing the risk of cross-contamination, making them particularly popular in clinical settings. The growing emphasis on single-use devices to prevent infections has further bolstered the demand for plastic tuberculin syringes. As a result, they hold a significant share in the overall market, appealing to both healthcare providers and patients alike.

Glass Tuberculin Syringe:

Glass tuberculin syringes, while less common than their plastic counterparts, are still utilized in specific applications requiring high precision. Glass syringes are reusable and can be sterilized, making them an attractive option for certain healthcare environments. Their ability to provide accurate measurements is highly valued, particularly in lab settings or specialized clinics. However, the need for thorough cleaning and sterilization may limit their use in general practice, with disposable options being more prevalent. Nevertheless, glass tuberculin syringes maintain a niche presence in the market due to their reliability and effectiveness.

Metal Tuberculin Syringe:

Metal tuberculin syringes are primarily used for specialized applications, often in research or laboratory settings. These syringes offer durability and can withstand repeated usage and sterilization processes without compromising performance. The resistance to chemical corrosion makes metal syringes suitable for specific injectable substances. However, their weight and potential for higher costs compared to disposable options limit their popularity in routine clinical use. Despite this, metal tuberculin syringes continue to serve an essential role in particular segments of the market, ensuring their relevance amidst the proliferation of disposable plastic syringes.

Others:

The 'Others' category encompasses various alternative materials and custom syringe designs that cater to unique requirements within the tuberculin syringe market. This may include biodegradable syringes aimed at minimizing environmental impact, or specialized syringes designed for specific medical conditions or patient populations. As healthcare industries evolve, there is an increasing interest in developing innovative syringe solutions that meet diverse patient needs while adhering to safety and efficacy standards. The presence of alternative material options within the market reflects the ongoing commitment to enhancing patient care and addressing environmental concerns.

By Region

The North America region holds a dominant position in the global tuberculin syringe market, accounting for nearly 35% of the overall market share in 2023. The region benefits from advanced healthcare infrastructure, high levels of awareness regarding tuberculosis screening, and robust government initiatives aimed at controlling the disease. Additionally, the prevalence of hospitals and clinics equipped with state-of-the-art technology enhances the demand for tuberculin syringes. The North American market is projected to grow at a CAGR of around 5.8% over the forecast period, fueled by continuous advancements in syringe design and an ongoing commitment to improving public health outcomes.

In Europe, the tuberculin syringe market is experiencing steady growth, accounting for approximately 30% of the global market share. Countries like Germany, France, and the UK are focusing on enhancing TB screening and management protocols, leading to increased usage of tuberculin syringes in healthcare settings. The European market is expected to witness a CAGR of 5.4% through 2035 as public health initiatives emphasize early diagnosis and treatment of tuberculosis, and healthcare systems adapt to meet growing patient needs. The rising number of diagnostic centers and clinics across the region contributes to the increasing demand for tuberculin syringes.

Opportunities

The tuberculin syringe market presents numerous opportunities for growth, particularly within emerging economies where healthcare infrastructure is rapidly developing. As nations focus on improving public health outcomes and addressing the burden of communicable diseases, the demand for effective diagnostic tools, including tuberculin syringes, is expected to rise. Collaborations between government health agencies and private companies to enhance awareness of tuberculosis screening and testing will provide significant market opportunities. Additionally, the increasing trend towards home-based healthcare presents a unique avenue for expanding distribution channels, creating a greater need for convenient access to tuberculin syringes.

Moreover, advancements in syringe technology, such as the development of smart syringes equipped with dosage tracking capabilities, present new opportunities for market players. These innovations can further enhance patient safety and compliance, aligning with the growing emphasis on personalized healthcare. By investing in research and development, companies can capitalize on emerging trends and position themselves favorably within a competitive market landscape. With the ongoing push for preventive healthcare measures, organizations focusing on improving the overall safety and efficacy of tuberculosis testing are likely to thrive in the evolving tuberculin syringe market.

Threats

Despite the positive growth outlook for the tuberculin syringe market, several threats could impede its progress. The emergence of alternative diagnostic methods, such as molecular testing for tuberculosis, poses a significant challenge to traditional tuberculin testing. As healthcare providers begin to adopt more advanced diagnostics, the reliance on tuberculin syringes may decline, potentially impacting market growth. Additionally, stringent regulatory requirements surrounding the manufacturing and distribution of medical supplies can introduce barriers for small manufacturers trying to enter the market. Compliance with these regulations can lead to increased operational costs, further complicating market dynamics.

Restrainer

One of the primary restrainers affecting the tuberculin syringe market is the increasing trend towards needle-free injection systems. Such technologies eliminate the need for traditional syringes, thereby reducing the demand for tuberculin syringes in certain applications. While these innovations present benefits in terms of user safety and ease of administration, they may divert attention and resources away from conventional syringe usage. Furthermore, the cost associated with implementing new injection technologies could limit the market's overall growth, particularly in resource-limited settings where budget constraints are a concern. Therefore, the shift towards alternative injection methods may create challenges for the future of the tuberculin syringe market.

Competitor Outlook

• BD (Becton, Dickinson and Company)
• Terumo Corporation
• Smiths Medical
• Covidien (Medtronic)
• Hamilton Company
• Roche Diagnostics
• Greiner Bio-One International GmbH
• Nipro Corporation
• Cardinal Health, Inc.
• Schott AG
• Medline Industries, Inc.
• Fresenius Kabi AG
• Vygon S.A.
• Sterimed Group
• Ypsomed AG

The competitive landscape of the tuberculin syringe market is characterized by a mix of established companies and emerging players, each striving to capture market share through innovative product offerings and strategic partnerships. Major companies such as BD, Terumo Corporation, and Medtronic have a strong foothold in the market, driven by their extensive product portfolios and commitment to quality. These firms invest heavily in research and development to enhance existing products and introduce new syringes that meet evolving healthcare needs. Additionally, their established distribution networks enable them to reach a wider audience, solidifying their positions as market leaders.

Emerging players in the tuberculin syringe market are also making their presence felt through niche product offerings and targeted marketing strategies. Companies like Schott AG and Nipro Corporation focus on manufacturing high-quality glass and plastic syringes, catering to specific client demands for accuracy and safety. These innovative companies often seek to capitalize on trends such as safety syringes and low dead space designs, providing competitive alternatives to traditional products. By leveraging their agility and responsiveness to market demands, these emerging players can effectively compete in an increasingly crowded marketplace.

Furthermore, collaboration and partnerships among key industry players are shaping the future of the tuberculin syringe market. Strategic alliances between manufacturers, healthcare providers, and research institutions can facilitate the development of advanced syringe technologies and improve market penetration. For instance, companies may collaborate on initiatives aimed at improving tuberculosis screening processes, leveraging collective expertise to enhance product efficacy and safety. As the market continues to evolve, these collaborations will play a crucial role in driving innovation and addressing challenges, ensuring sustainable growth within the tuberculin syringe sector.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Schott AG
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Vygon S.A.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Ypsomed AG
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Smiths Medical
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Sterimed Group
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Hamilton Company
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fresenius Kabi AG
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Nipro Corporation
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Roche Diagnostics
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Terumo Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Covidien (Medtronic)
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cardinal Health, Inc.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Medline Industries, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 BD (Becton, Dickinson and Company)
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Greiner Bio-One International GmbH
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Tuberculin Syringe Market, By Application
    • 6.1.1 Hospitals
    • 6.1.2 Clinics
    • 6.1.3 Diagnostic Centers
    • 6.1.4 Homecare Settings
    • 6.1.5 Others
  • 6.2 Tuberculin Syringe Market, By Product Type
    • 6.2.1 Fixed Needle Tuberculin Syringe
    • 6.2.2 Detachable Needle Tuberculin Syringe
    • 6.2.3 Safety Tuberculin Syringe
    • 6.2.4 Retractable Tuberculin Syringe
    • 6.2.5 Low Dead Space Tuberculin Syringe
  • 6.3 Tuberculin Syringe Market, By Material Type
    • 6.3.1 Plastic Tuberculin Syringe
    • 6.3.2 Glass Tuberculin Syringe
    • 6.3.3 Metal Tuberculin Syringe
    • 6.3.4 Others
  • 6.4 Tuberculin Syringe Market, By Distribution Channel
    • 6.4.1 Hospitals Pharmacies
    • 6.4.2 Retail Pharmacies
    • 6.4.3 Online Pharmacies
    • 6.4.4 Drug Stores
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Tuberculin Syringe Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Tuberculin Syringe market is categorized based on

By Product Type

• Fixed Needle Tuberculin Syringe
• Detachable Needle Tuberculin Syringe
• Safety Tuberculin Syringe
• Retractable Tuberculin Syringe
• Low Dead Space Tuberculin Syringe

By Application

• Hospitals
• Clinics
• Diagnostic Centers
• Homecare Settings
• Others

By Distribution Channel

• Hospitals Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Drug Stores
• Others

By Material Type

• Plastic Tuberculin Syringe
• Glass Tuberculin Syringe
• Metal Tuberculin Syringe
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• BD (Becton, Dickinson and Company)
• Terumo Corporation
• Smiths Medical
• Covidien (Medtronic)
• Hamilton Company
• Roche Diagnostics
• Greiner Bio-One International GmbH
• Nipro Corporation
• Cardinal Health, Inc.
• Schott AG
• Medline Industries, Inc.
• Fresenius Kabi AG
• Vygon S.A.
• Sterimed Group
• Ypsomed AG